January 29, 2015 2:47 AM ET

Pharmaceuticals

Company Overview of Stempar Sciences, Inc.

Company Overview

Stempar Sciences, Inc. develops drugs for pancreatic, breast, and lung cancers. The company’s lead program is SPS-201, a therapeutic agent, which targets an enzyme frequently expressed at high levels by tumors. Its cancer drugs attacks solid tumors by simultaneously disrupting their source of energy and are able to repair chemotherapy/radiation induced DNA damage. The company also develops companion diagnostic tests to detect the NQO1 target protein. Stempar Sciences, Inc. was founded in 2009 and is based in Mill Valley, California.

35 Miller Avenue

Suite 220

Mill Valley, CA 94941

United States

Founded in 2009

Phone:

415-264-6223

Key Executives for Stempar Sciences, Inc.

Chief Executive Officer and President
Age: 72
Chief Financial Officer and Vice President
Scientific Advisor
Scientific Advisor
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Pro Pac Labs, Inc. United States
Prestige Brands International, Inc. United States
Optimer Pharmaceuticals, Inc. United States
ALIGN Pharmaceuticals, LLC United States
Seldar Pharma, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Stempar Sciences, Inc., please visit stempar.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.